Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Neramexane shows promise for the treatment of alcohol dependence

Nov. 18, 2003

TA-CD advances into phase IIb for cocaine addiction

Oct. 28, 2003

TA-NIC enters second phase I trial

Oct. 10, 2003

Potential benefits reported for the anticonvulsant vigabatrin in cocaine addiction

Oct. 7, 2003

SSR-591813, a partial alpha4beta2 nAChR agonist, effective in animal models of nicotine dependence

Aug. 29, 2003

New phase II trial evaluates NicVAX in smokers

Aug. 7, 2003

JT patent covers new inhibitors of sodium-phosphate cotransporter and their use

Aug. 6, 2003

Completion of phase I study of vaccinia immune globulin

Aug. 5, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...